肼屈嗪血浆浓度与剂量及降压作用的关系。 - Suppr

Suppr

超能文献

Relation of hydralazine plasma concentration to dosage and hypotensive action.

作者信息

Zacest R, Koch-Weser J

出版信息

Clin Pharmacol Ther. 1972 May-Jun;13(3):420-5. doi: 10.1002/cpt1972133420.

DOI:10.1002/cpt1972133420

PMID:5026380

Abstract

摘要

相似文献

Relation of hydralazine plasma concentration to dosage and hypotensive action.

Clin Pharmacol Ther. 1972 May-Jun;13(3):420-5. doi: 10.1002/cpt1972133420.

Plasma concentration and acetylator phenotype determine response to oral hydralazine.

Hypertension. 1981 Sep-Oct;3(5):580-5. doi: 10.1161/01.hyp.3.5.580.

Acetylator phenotype and the antihypertensive response to hydralazine.

Acta Med Scand. 1975 Apr;197(4):303-6. doi: 10.1111/j.0954-6820.1975.tb04922.x.

Hydralazine slow-release: observations on serum profile and clinical efficacy in man.

Curr Ther Res Clin Exp. 1977 Feb;21(2):157-68.

Effect of food on blood hydralazine levels and response in hypertension.

Clin Pharmacol Ther. 1984 Jul;36(1):14-8. doi: 10.1038/clpt.1984.131.

[Slow-release hydralazine in the treatment of essential arterial hypertension].

Arq Bras Cardiol. 1982 Sep;39(3):197-9.

Determinants of response to intravenous hydralazine in hypertension.

Clin Pharmacol Ther. 1981 Dec;30(6):773-81. doi: 10.1038/clpt.1981.237.

Propranolol given twice daily in hypertension.

Acta Med Scand. 1973 Dec;194(6):513-5. doi: 10.1111/j.0954-6820.1973.tb19483.x.

Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade.

N Engl J Med. 1972 Mar 23;286(12):617-22. doi: 10.1056/NEJM197203232861201.

Effect of oral dose size on hydralazine kinetics and vasodepressor response.

Clin Pharmacol Ther. 1984 Nov;36(5):595-600. doi: 10.1038/clpt.1984.227.

引用本文的文献

Pharmacogenomics Informs Cardiovascular Pharmacotherapy.

Methods Mol Biol. 2022;2547:201-240. doi: 10.1007/978-1-0716-2573-6_9.

Genotype-Guided Hydralazine Therapy.

Am J Nephrol. 2020;51(10):764-776. doi: 10.1159/000510433. Epub 2020 Sep 14.

Hydralazine induces Z-DNA conformation in a polynucleotide and elicits anti(Z-DNA) antibodies in treated patients.

Biochem J. 1993 Sep 1;294 ( Pt 2)(Pt 2):419-25. doi: 10.1042/bj2940419.

Double-blind cross-over comparison of hydralazine and prazosin in hypertensive subjects on a beta-adrenoceptor blocking agent (atenolol).

Br J Clin Pharmacol. 1980 Nov;10(5):531-3. doi: 10.1111/j.1365-2125.1980.tb01802.x.

Disposition and pharmacodynamics of diuretics and antihypertensive agents in renal disease.

Eur J Clin Pharmacol. 1980 Jul;18(1):109-16. doi: 10.1007/BF00561487.

Pharmacokinetics of hydralazine and its acid-labile hydrazone metabolites in relation to acetylator phenotype.

J Pharmacokinet Biopharm. 1980 Feb;8(1):53-68. doi: 10.1007/BF01059448.

Effect of food on the absorption of hydralazine in man.

Eur J Clin Pharmacol. 1981;20(1):53-8. doi: 10.1007/BF00554667.

The hypotensive response to hydralazine, in triple therapy, is not related to acetylator phenotype.

Br J Clin Pharmacol. 1982 May;13(5):747-50. doi: 10.1111/j.1365-2125.1982.tb01452.x.

Clinical pharmacokinetics of hydralazine.

Clin Pharmacokinet. 1982 May-Jun;7(3):185-205. doi: 10.2165/00003088-198207030-00001.

Antihypertensive pharmacology.

West J Med. 1980 May;132(5):430-9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验